MM Hoper, NF Voelkel, TO Bates, JD Allard, M Horan, D Shepherd and RM Tuder
Department of Pathology, Pulmonary Hypertension Center, and University of Colorado Health Sciences Center, Denver 80262, USA.

Prostaglandins have emerged as a therapeutic option for patients with peripheral vascular disease as well as pulmonary hypertension as a means to increase blood flow. We tested the hypothesis that prostaglandins regulate vascular endothelial growth factor (VEGF) expression in the human monocytic THP-1 cell line and in isolated perfused rat lungs. Our data show that the stable PGI2-analogue iloprost induces VEGF gene expression (predominantly VEGF121, but also VEGF165 isoforms) and VEGF protein synthesis in THP-1 cells. This effect is abolished by dexamethasone and by Rp-cAMP, a specific inhibitor of cAMP-dependent protein kinase (PKA) activation. The calcium channel blocker diltiazem has no effect on the iloprost-induced VEGF gene expression, and depletion of intracellular Ca2+ stores by long-term exposure (16 h) of THP-1 cells to thapsigargin does not inhibit iloprost-induced VEGF gene expression, suggesting that an increase in intracellular Ca2+ is not essential for VEGF gene induction by iloprost. However, an increase of intracellular Ca2+ by a short-term (2 h) exposure of THP-1 cells to thapsigargin or to the calcium- ionophore A23187 increases VEGF mRNA levels, indicating that a change in intracellular Ca2+ by itself can alter VEGF gene expression. The effects of thapsigargin or A23187 on VEGF gene expression are also mediated via cAMP-PKA since they are inhibited by Rp-cAMP. In isolated perfused rat lungs, PGI2 and PGE2 increases VEGF mRNA abundance whereas Rp-cAMP inhibits the prostaglandin-induced VEGF gene activation. Thus, our data suggest that prostaglandins stimulate VEGF gene expression in monocytic cells and in rat lungs via a cAMP-dependent mechanism.

This article has been cited by other articles:

				E. T. Lam, C. L. O'Bryant, M. Basche, D. L. Gustafson, N. Serkova, A. Baron, S. N. Holden, J. Dancey, S. G. Eckhardt, and L. Gore A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors Mol. Cancer Ther., December 1, 2008; 7(12): 3685 - 3694. [Abstract] [Full Text] [PDF]

				A. Tzankov, S. Heiss, S. Ebner, W. Sterlacci, G. Schaefer, F. Augustin, M. Fiegl, and S. Dirnhofer Angiogenesis in nodal B cell lymphomas: a high throughput study J. Clin. Pathol., May 1, 2007; 60(5): 476 - 482. [Abstract] [Full Text] [PDF]

				J. Cao, C. L. Cetrulo, and T. C. Theoharides Corticotropin-Releasing Hormone Induces Vascular Endothelial Growth Factor Release from Human Mast Cells via the cAMP/Protein Kinase A/p38 Mitogen-Activated Protein Kinase Pathway Mol. Pharmacol., March 1, 2006; 69(3): 998 - 1006. [Abstract] [Full Text] [PDF]

				Y. M. Sung, G. He, and S. M. Fischer Lack of Expression of the EP2 but not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin Tumor Development Cancer Res., October 15, 2005; 65(20): 9304 - 9311. [Abstract] [Full Text] [PDF]

				S. Kanazawa, K. Yamaguchi, Y. Kinoshita, M. Muramatsu, Y. Komiyama, and S. Nomura Gefitinib Affects Functions of Platelets and Blood Vesselsvia Changes in Prostanoids Balance Clinical and Applied Thrombosis/Hemostasis, October 1, 2005; 11(4): 429 - 434. [Abstract] [PDF]

				R. Fux, M. Schwab, K.-P. Thon, C. H. Gleiter, and P. Fritz Cyclooxygenase-2 Expression in Human Colorectal Cancer Is Unrelated to Overall Patient Survival Clin. Cancer Res., July 1, 2005; 11(13): 4754 - 4760. [Abstract] [Full Text] [PDF]

				R. T. Schermuly, K. P. Kreisselmeier, H. A. Ghofrani, A. Samidurai, S. Pullamsetti, N. Weissmann, C. Schudt, L. Ermert, W. Seeger, and F. Grimminger Antiremodeling Effects of Iloprost and the Dual-Selective Phosphodiesterase 3/4 Inhibitor Tolafentrine in Chronic Experimental Pulmonary Hypertension Circ. Res., April 30, 2004; 94(8): 1101 - 1108. [Abstract] [Full Text] [PDF]

				C. Y. Cheung Vascular Endothelial Growth Factor Activation of Intramembranous Absorption: A Critical Pathway for Amniotic Fluid Volume Regulation Reproductive Sciences, February 1, 2004; 11(2): 63 - 74. [Abstract] [PDF]

				Y. Numaguchi, K. Okumura, M. Harada, K. Naruse, M. Yamada, H. Osanai, H. Matsui, M. Ito, and T. Murohara Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries Cardiovasc Res, January 1, 2004; 61(1): 177 - 185. [Abstract] [Full Text] [PDF]

				M. ROMANO and J. CLARIA Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy FASEB J, November 1, 2003; 17(14): 1986 - 1995. [Abstract] [Full Text] [PDF]

				W. J. Lukiw, A. Ottlecz, G. Lambrou, M. Grueninger, J. Finley, H. W. Thompson, and N. G. Bazan Coordinate Activation of HIF-1 and NF-{kappa}B DNA Binding and COX-2 and VEGF Expression in Retinal Cells by Hypoxia Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4163 - 4170. [Abstract] [Full Text] [PDF]

				R. J. K. Anand, H.-J. Paust, K. Altenpohl, and A. K. Mukhopadhyay Regulation of Vascular Endothelial Growth Factor Production by Leydig Cells In Vitro: The Role of Protein Kinase A and Mitogen-Activated Protein Kinase Cascade Biol Reprod, May 1, 2003; 68(5): 1663 - 1673. [Abstract] [Full Text] [PDF]

				H. Amano, I. Hayashi, H. Endo, H. Kitasato, S. Yamashina, T. Maruyama, M. Kobayashi, K. Satoh, M. Narita, Y. Sugimoto, et al. Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth J. Exp. Med., January 20, 2003; 197(2): 221 - 232. [Abstract] [Full Text] [PDF]

				K. Takahashi, Y. Saishin, Y. Saishin, K. Mori, A. Ando, S. Yamamoto, Y. Oshima, H. Nambu, M. B. Melia, D. P. Bingaman, et al. Topical Nepafenac Inhibits Ocular Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 409 - 415. [Abstract] [Full Text] [PDF]

				X. H. Liu, A. Kirschenbaum, M. Lu, S. Yao, A. Dosoretz, J. F. Holland, and A. C. Levine Prostaglandin E2 Induces Hypoxia-inducible Factor-1alpha Stabilization and Nuclear Localization in a Human Prostate Cancer Cell Line J. Biol. Chem., December 13, 2002; 277(51): 50081 - 50086. [Abstract] [Full Text] [PDF]

				M. R. Mehrabi, N. Serbecic, F. Tamaddon, C. Kaun, K. Huber, R. Pacher, T. Wild, G. Mall, J. Wojta, and H.-D Glogar Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease Cardiovasc Res, November 1, 2002; 56(2): 214 - 224. [Abstract] [Full Text] [PDF]

				O. Sitbon, M. Humbert, H. Nunes, F. Parent, G. Garcia, P. Herve, M. Rainisio, and G.e. Simonneau Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival J. Am. Coll. Cardiol., August 21, 2002; 40(4): 780 - 788. [Abstract] [Full Text] [PDF]

				S. F. Abcouwer, P. L. Marjon, R. K. Loper, and D. L. Vander Jagt Response of VEGF Expression to Amino Acid Deprivation and Inducers of Endoplasmic Reticulum Stress Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2791 - 2798. [Abstract] [Full Text] [PDF]

				N. L. Derevjanik, S. A. Vinores, W.-H. Xiao, K. Mori, T. Turon, T. Hudish, S. Dong, and P. A. Campochiaro Quantitative Assessment of the Integrity of the Blood-Retinal Barrier in Mice Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2462 - 2467. [Abstract] [Full Text] [PDF]

				M. M. Hoeper, N. Galie, G. Simonneau, and L. J. Rubin New Treatments for Pulmonary Arterial Hypertension Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1209 - 1216. [Full Text] [PDF]

				J. M. Wallace Nutritional and Botanical Modulation of the Inflammatory Cascade--Eicosanoids, Cyclooxygenases, and Lipoxygenases-- As an Adjunct in Cancer Therapy Integr Cancer Ther, March 1, 2002; 1(1): 7 - 37. [Abstract] [PDF]

				I. M. Fierro, J. L. Kutok, and C. N. Serhan Novel Lipid Mediator Regulators of Endothelial Cell Proliferation and Migration: Aspirin-Triggered-15R-Lipoxin A4 and Lipoxin A4 J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 385 - 392. [Abstract] [Full Text] [PDF]

				M. ROMANO, A. CATALANO, M. NUTINI, E. D'URBANO, C. CRESCENZI, J. CLARIA, R. LIBNER, G. DAVI, and A. PROCOPIO 5-Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor FASEB J, November 1, 2001; 15(13): 2326 - 2336. [Abstract] [Full Text] [PDF]

				A. J. KNOX, L. CORBETT, J. STOCKS, E. HOLLAND, Y. M. ZHU, and L. PANG Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism FASEB J, November 1, 2001; 15(13): 2480 - 2488. [Abstract] [Full Text] [PDF]

				R. J. Bing, M. Miyataka, K. A. Rich, N. Hanson, X. Wang, H. D. Slosser, and S.-R. Shi Nitric Oxide, Prostanoids, Cyclooxygenase, and Angiogenesis in Colon and Breast Cancer Clin. Cancer Res., November 1, 2001; 7(11): 3385 - 3392. [Abstract] [Full Text] [PDF]

				E. Fosslien Molecular Pathology of Cyclooxygenase-2 in Cancer-induced Angiogenesis Ann. Clin. Lab. Sci., October 1, 2001; 31(4): 325 - 348. [Abstract] [Full Text] [PDF]

				E. C. Jaeckel, S. Raja, J. Tan, S. K. Das, S. K. Dey, D. A. Girod, T. T. Tsue, and T. R. Sanford Correlation of Expression of Cyclooxygenase-2, Vascular Endothelial Growth Factor, and Peroxisome Proliferator-Activated Receptor {delta} With Head and Neck Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, October 1, 2001; 127(10): 1253 - 1259. [Abstract] [Full Text] [PDF]

				S. A. Milne, G. B. Perchick, S. C. Boddy, and H. N. Jabbour Expression, Localization, and Signaling of PGE2 and EP2/EP4 Receptors in Human Nonpregnant Endometrium across the Menstrual Cycle J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4453 - 4459. [Abstract] [Full Text] [PDF]

				S. EDDAHIBI, M. HUMBERT, S. SEDIAME, C. CHOUAID, C. PARTOVIAN, B. MAITRE, E. TEIGER, D. RIDEAU, G. SIMONNEAU, O. SITBON, et al. Imbalance between Platelet Vascular Endothelial Growth Factor and Platelet-derived Growth Factor in Pulmonary Hypertension . Effect of Prostacyclin Therapy Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1493 - 1499. [Abstract] [Full Text] [PDF]

				M. M. Hoeper, M. Schwarze, S. Ehlerding, A. Adler-Schuermeyer, E. Spiekerkoetter, J. Niedermeyer, M. Hamm, and H. Fabel Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue N. Engl. J. Med., June 22, 2000; 342(25): 1866 - 1870. [Abstract] [Full Text] [PDF]

				J. M. Fredriksson, J. M. Lindquist, G. E. Bronnikov, and J. Nedergaard Norepinephrine Induces Vascular Endothelial Growth Factor Gene Expression in Brown Adipocytes through a beta -Adrenoreceptor/cAMP/Protein Kinase A Pathway Involving Src but Independently of Erk1/2 J. Biol. Chem., April 28, 2000; 275(18): 13802 - 13811. [Abstract] [Full Text] [PDF]

				M. M. Hoeper, H. Olschewski, H. A. Ghofrani, H. Wilkens, J. Winkler, M. M. Borst, J. Niedermeyer, H. Fabel, W. Seeger, and the German PPH Study Group A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension J. Am. Coll. Cardiol., January 1, 2000; 35(1): 176 - 182. [Abstract] [Full Text] [PDF]

				H. Benoit, M. Jordan, H. Wagner, and P. D. Wagner Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression J Appl Physiol, May 1, 1999; 86(5): 1513 - 1518. [Abstract] [Full Text] [PDF]

				A. K. Ghosh, N. Hirasawa, H. Ohtsu, T. Watanabe, and K. Ohuchi Defective Angiogenesis in the Inflammatory Granulation Tissue in Histidine Decarboxylase-deficient Mice but not in Mast Cell-deficient Mice J. Exp. Med., April 15, 2002; 195(8): 973 - 982. [Abstract] [Full Text] [PDF]